Archives of Disease in Childhood - Fetal and Neonatal Edition 2008;93:F280-F285
ORIGINAL ARTICLES
Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss
1 St George’s Hospital, Blackshaw Road, Tooting, London SW17 0QT, UK
2 Centre for Virology, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
Correspondence to:
Dr Simone Walter, Department of Audiological Medicine, Great Ormond Street Hospital, Great Ormond Street, London WC1N 3JH, UK; waltes{at}gosh.nhs.uk
Aim: To investigate the relation between cytomegalovirus (CMV) viral load on dried blood spots (DBS) from newborn biochemical screening ("Guthrie") cards, and sensorineural hearing loss (SNHL) in congenital CMV.
Design: Cross-sectional study with retrospective case-note review.
Setting: Seven paediatric audiology departments in the United Kingdom.
Patients: 84 children, median age 7 years: 43 with known congenital CMV, 41 with unexplained SNHL.
Interventions: Half a DBS was tested for CMV DNA viral load by quantitative real-time polymerase chain reaction (PCR).
Main outcome measures: Pure tone average hearing thresholds (0.5–4 kHz).
Results: DBS CMV DNA viral load significantly correlated with hearing thresholds for the worse and better hearing ears (Spearman’s rank correlations: r = 0.445, p = 0.008 and r = 0.481, p = 0.004 respectively). Multivariable logistic regression showed that the effect of DBS viral load on the risk of SNHL remained important, when age and central nervous system involvement had been taken into account (odds ratio (OR) 2.76, 95% confidence interval (CI) 1.14 to 6.63, p = 0.024). The mean log DBS viral load was significantly higher in children with SNHL than in those with normal hearing (2.69 versus 1.64, 95% CI –1.84 to –0.27, p = 0.01). 8/35 (23%) children with unexplained SNHL tested positive for CMV DNA on DBS. One false positive result was obtained.
Conclusion: The risk of SNHL increased with DBS viral load. Further studies should investigate whether DBS CMV testing has a role in identifying asymptomatic congenitally infected neonates at risk of SNHL, and whether antiviral treatment can reduce this risk.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
-
All Versions of this Article:
adc.2007.119230v1
93/4/F280 most recent - Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in ADC Online
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Epidemiologic studies
-
Drugs: infectious diseases
-
Child health
-
Ear, nose and throat/otolaryngology
-
Screening (epidemiology)
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
